UGA- CNRS, CERMAV, BP53X, 38041 Grenoble Cedex, France.
UGA- CNRS, CERMAV, BP53X, 38041 Grenoble Cedex, France.
Carbohydr Polym. 2017 Jul 1;167:123-128. doi: 10.1016/j.carbpol.2017.03.026. Epub 2017 Mar 10.
Conjugatable glycosaminoglycans hold promise for medical applications involving the vectorization of specific molecules. Here, we set out to produce bacterial chondroitin and heparosan from a conjugatable precursor using metabolically engineered Escherichia coli strains. The major barrier to this procedure was the glucuronylation of a lactosyl acceptor required for polymerization. To overcome this barrier, we designed E. coli strains expressing mouse β-1,3-glucuronyl transferase and E. coli K4 chondroitin and K5 heparosan synthases. These engineered strains were cultivated at high density in presence of a lactose-furyl precursor. Enzymatic polymerization occurred on the lactosyl precursor resulting in small chains ranging from 15 to 30kDa that accumulated in the cytoplasm. Furyl-terminated polysaccharides were produced at a gram-per-liter scale, a yield similar to that reported for conventional strains. Their efficient conjugation using a Diels-Alder cycloaddition reaction in aqueous and catalyst-free conditions was also confirmed using N-methylmaleimide as model dienophile.
可结合的糖胺聚糖有望在涉及特定分子载体化的医学应用中得到应用。在这里,我们着手使用代谢工程大肠杆菌菌株从可结合的前体中生产细菌软骨素和肝素。该方法的主要障碍是聚合所需的乳糖基受体的葡萄糖醛酸化。为了克服这一障碍,我们设计了表达小鼠β-1,3-葡糖醛酸转移酶和大肠杆菌 K4 软骨素和 K5 肝素合酶的大肠杆菌菌株。这些工程菌株在含有乳糖糠基前体的情况下进行高密度培养。在乳糖基前体上发生酶聚合反应,导致在细胞质中积累从小至 15 至 30 kDa 的小链。呋喃基末端多糖以克/升的规模生产,产率与传统菌株报道的产率相似。使用 N-甲基马来酰亚胺作为模型双烯体,在水相和无催化剂条件下,通过 Diels-Alder 环加成反应也证实了它们的有效结合。